Showing results (411-420 of 501) with videos related to
Sort By:
Pageof 51
Journal of Molecular Biology|August 5, 1993
Structure of human des(1-45) factor Xa at 2.2 A resolutionK Padmanabhan, K P Padmanabhan, A Tulinsky, et al.BMJ Open Diabetes Research & Care|December 15, 2020
Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trialJohn B Buse, Bruce W Bode, Ann Mertens, et al.Acta Crystallographica. Section D, Biological Crystallography|February 10, 2000
Crystallization and preliminary X-ray analysis of recombinant full-length human m-calpainH Masumoto, K Nakagawa, S Irie, et al.RSC Chemical Biology|June 27, 2022
Chemical synthesis of Torenia plant pollen tube attractant proteins by KAHA ligationNandarapu Kumarswamyreddy, Damodara N Reddy, D Miklos Robkis, et al.Diabetes, Obesity & Metabolism|August 27, 2014
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metforminJ Reusch, M W Stewart, C M Perkins, et al.The Diabetes Educator|April 9, 2016
Improving Patient Experience With Insulin Infusion Sets: Practical Guidelines and Future DirectionsAlison B Evert, Bruce W Bode, Bruce A Buckingham, et al.Diabetes, Obesity & Metabolism|May 19, 2015
One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trialS C L Gough, B W Bode, V C Woo, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 27, 2024
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2Jinling Wang, Darja Beyer, Christian Vaccarin, et al.Proceedings of the National Academy of Sciences of the United States of America|August 30, 1994
Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d)D Zhang, I Botos, F X Gomis-Rüth, et al.Journal of Diabetes Science and Technology|August 25, 2016
Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital SettingJoseph Aloi, Bruce W Bode, Jagdeesh Ullal, et al.Pageof 51